Ozempic and Zepbound are both prescription injections that are part of the GLP-1 drug class. They have different active ...

Thirty-nine percent of millennials and 35% of Gen Z say access to weight loss drugs would improve their job satisfaction or ...

Lawmakers are trying to restore access to GLP-1 weight loss drugs, like Ozempic and Wegovy, after Ohio removed medical ...

Novo Nordisk reportedly failed to pay its annual fees to maintain the patent rights in Canada, opening the door to cheaper ...

From supplements to injectables to belly-fat blasting beverages, there are plenty of products that claim to speed weight loss ...

GLP-1 drugs for diabetes and weight loss are difficult for some people to inject weekly. A new slow-release gel, tested in rats, could help.

Offering a rare glimpse inside the hidden world of rejected insurance claims, new data shows a steady uptick among major ...

Demand for glucagon-like peptide-1 weight-loss drugs — such as Ozempic, Zepbound and Wegovy — coupled with limited insurance ...

More than 1,000 exhibitors attended this year's Institute of Food Technologists expo, with some Illinois companies sharing ...

Bega Group is bulking up its share of the $600m high-protein flavoured milk category as it positions the business to grow as ...

Some people are discovering that being thinner can sometimes mean looking older. Local cosmetic surgeons weigh-in with ...

Eating disorder centers are facing an influx of people with weight-loss prescriptions. Experts say doctors are ...